Pharmaceuticals
Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.
Pharmaceuticals
32
results for
Pharmaceuticals
Filters
Refine your search
Excipient designed for pharmaceutical applications. It is used
to adjust pH in solid and semi-solid dosage formulations.Benefits:
- Complies with USP, Ph Eur and CP specifications
TDS
Excipient developed for pharmaceutical applications. It functions as a preservative in solid and semi-solid
dosage forms. Benefits:
- Meets with CDMF specifications
TDS
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20190000639
TDS
Excipient having possible use in pharmaceutical applications.
TDS
Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
- It maintains low level of endotoxins with the bioburden limits- BET/MLT
- Controlled metallic impurities
- Developed for…
TDS
Excipient for use in pharmaceutical applications. It acts as a preservative.
TDS
Antioxidant for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
- DMF filed excipient - CDE # F20200000188
- All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
TDS
Excipient developed for pharmaceutical applications. It acts as an antioxidant.
TDS
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
- DMF filed excipient - CDE # F20200000188
- All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
TDS
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
- DMF filed excipient - CDE # F20200000188
- All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
TDS
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
- Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
- DMF Filed - CDE # F20200000189
TDS
Excipient designed for pharmaceutical applications. It acts as a stabilizer.
TDS